Zymeworks Inc.
ZYME
$27.50
-$0.62-2.19%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 90.61% | -4.25% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 90.61% | -4.25% | |||
| Cost of Revenue | -20.38% | 10.32% | |||
| Gross Profit | 28.72% | -11.59% | |||
| SG&A Expenses | 28.31% | -2.35% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.56% | 6.13% | |||
| Operating Income | 10.48% | -6.72% | |||
| Income Before Tax | 2.29% | -11.75% | |||
| Income Tax Expenses | 87.54% | -711.48% | |||
| Earnings from Continuing Operations | -1.94% | -7.17% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -1.94% | -7.17% | |||
| EBIT | 10.48% | -6.72% | |||
| EBITDA | 10.73% | -6.76% | |||
| EPS Basic | -4.29% | -8.12% | |||
| Normalized Basic EPS | 0.05% | -12.76% | |||
| EPS Diluted | -4.73% | -8.23% | |||
| Normalized Diluted EPS | 0.03% | -12.73% | |||
| Average Basic Shares Outstanding | -2.24% | -0.89% | |||
| Average Diluted Shares Outstanding | -2.28% | -0.85% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||